AFCG Advanced Flower Capital Inc.
· Nasdaq · SEC CIK 1822523 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-46.2%
TTM net income YoY-223.2%
TTM EPS YoY-221.8%
Revenue 3-yr CAGR-31.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-84.2%
FCF margin—
EBITDA margin—
Returns
ROE-11.0%
ROA-6.1%
ROIC (approx.)—
Asset turnover0.07x
Leverage & solvency
Liabilities / assets36.3%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.54x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $24.56M | $45.66M | $63.93M | $74.68M | — |
| SG&A expense | $3.23M | $3.97M | $5.01M | $4.70M | $3.21M |
| Interest expense | $6.76M | $6.34M | $6.36M | $6.81M | $1.13M |
| Pretax income | -$21.29M | $14.31M | $22.38M | $36.96M | $21.04M |
| Income tax | -$613,379 | $447,587 | $1.66M | $1.03M | $35,167 |
| Net income | -$20.67M | $16.78M | $20.95M | $35.93M | $21.00M |
| EPS (basic) | -0.95 | 0.78 | 1.02 | 1.80 | 1.57 |
| EPS (diluted) | -0.95 | 0.78 | 1.02 | 1.79 | 1.52 |
| Dividends declared per share | 0.53 | 1.77 | 2.00 | 2.23 | 1.67 |
| Weighted avg. shares (diluted) | 22.28M | 20.89M | 20.35M | 19.96M | 13.81M |
| Banking | |||||
| Net interest income | — | — | — | $74.68M | $37.01M |
| Provision for credit losses | — | — | — | — | $2.65M |
| Loans, net | — | — | — | — | $257.26M |
| Balance sheet | |||||
| Cash & equivalents | $38.61M | $103.61M | $121.63M | $140.37M | $109.25M |
| Total assets | $275.59M | $402.06M | $466.59M | $519.18M | $464.85M |
| Total liabilities | $100.03M | $200.68M | $146.53M | $180.12M | $191.77M |
| Shareholders' equity | $175.57M | $201.38M | $320.05M | $339.06M | $273.08M |
| Shares outstanding | 23.53M | 22.33M | 20.46M | 20.36M | 16.44M |
| Cash flow statement | |||||
| Operating cash flow | $11.24M | $21.56M | $21.23M | $31.32M | $9.54M |
| Investing cash flow | $34.90M | -$4.85M | $28.52M | -$16.34M | -$248.46M |
| Financing cash flow | -$111.14M | -$34.72M | -$68.49M | $16.15M | $338.54M |
| Stock-based compensation | $6.84M | $1.39M | $988,913 | $1.34M | $1.75M |
| Dividends paid | — | — | — | $41.62M | $14.39M |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.